Issues
Impact of radiation on blood diseases in the participants of the Chernobyl nuclear power plant with consideration of multimorbidity
«Radiation and Risk», 2024, vol. 33, No. 1, pp.24-39
DOI: 10.21870/0131-3878-2024-33-1-24-39
Authors
Chekin S.Yu. – Head of Lab. Contacts: 4 Korolyov str., Obninsk, Kaluga region, Russia, 249035. Tel.: (484) 399-30-79; e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. .Gorski A.I. – Lead. Researcher, C. Sc., Tech.
Maksioutov M.A. – Head of Dep., C. Sc., Tech.
Karpenko S.V. – Engineer
Kochergina E.V. – Head of Lab., C. Sc., Med.
Zelenskaya N.S. – Researcher
Lashkova O.E. – Researcher. A. Tsyb MRRC.
A. Tsyb MRRC, Obninsk
Abstract
The statistical relationships between radiation doses and blood diseases with the account of the multimorbidity factor in the Russian cohort of workers involved in mitigation of the consequences of the accident at the Chernobyl NPP have been investigated. For analysis observation data accumulated from 1986 over 2022 kept in the National Radiation Epidemiological Register were used. The size of the liquidators cohort was 89,578 men. During the follow-up period 6,013 blood disorders (D50-D89 ICD-10) were detected for the first time. The average radiation dose in the cohort was 0.13 Gy, and the average age at the first exposure was 33.6 years. Common approaches to data mining (Data Mining) were used to identify statistical relationships between blood diseases and other diseases; for radiation risk assessment, logistic regression models were used to link disease probability to radiation dose. The effect of low-dose radiation (less than 0.3 Gy) on blood diseases is statistically significant and is characterized by a multiplicative linear no-threshold model, the dose-response model with ERR/Gy=0.59 at 95% CI (0.23; 0.99). When considering multimorbidity in patients, the blood dis-eases radiation risk change was not statistically significant. Radiation risks several times higher than risks of malignant neoplasms, were found in three groups of diseases: 1) blood and haemopoietic organs other than anaemia and hemorrhages (D70-D77), with ERR/Gy=2.25; 2) immunodeficiency states (D80-D89), with ERR/Gr=2.01; 3) aplastic anemias (D60-D61), with ERR/Gy=5.56. The inclusion of aplastic anaemia in the officially approved list of diseases caused by exposure to ionizing radiation in Russia should be considered as scientifically justified document. The list may need to be supplemented by diseases of blood and haemorrhagic organs other than anaemia and hemorrhage, as well as immunodeficiency conditions. The radiation risk coefficients (ERR/Gy) for the main groups of blood diseases estimated for the first time will make it possible to establish radiation dependence in exposed people with the use of a dose and radiation-epidemiological approach, estimating the attributive fraction of radiation in the etiology of each specific disease case.
Key words
liquidators, Chernobyl accident, external gamma radiation, blood diseases, multimorbidity, data mining, regression model, radiation risk, radiobiology, public health, radiation.
References
1. International Statistical Classification of Diseases and Related Health, 10th revision (ICD-10). Vol. 1 (Part 1). Geneva, WHO, 1995. 698 p. (In Russian).
2. Blood diseases: a list of the most dangerous. Available at: https://medicinehelpful.com/17332849-blood-dis-eases-a-list-of-the-most-dangerous (Accessed 10.02.2024).
3. Salerno S. Universal expositions, physics-chemistry and new occupational diseases: the case of Marie Sklodowska Curie and radium girls. Med. Lav., 2017, vol. 108, no. 1, pp. 69-79. DOI: 10.23749/mdl.v108i1.5698.
4. Ozasa K., Shimizu Y., Suyama A., Kasagi F., Soda M., Grant E.J., Sakata R., Sugiyama H., Kodama K. Studies of the mortality of atomic bomb survivors, Report 14, 1950-2003: an overview of cancer and non-cancer diseases. Radiat. Res., 2012, vol. 177, no. 3, pp. 229-243.
5. Brenner A.V., Preston D.L., Sakata R., Cologne J., Sugiyama H., Utada M., Cahoon E.K., Grant E., Mabuchi K., Ozasa K. Comparison of all solid cancer mortality and incidence dose-response in the Life Span Study of atomic bomb survivors, 1958-2009. Radiat. Res., 2022, vol. 197, no. 5, pp. 491-508.
6. Chekin S.Yu., Maksioutov M.A., Kashcheev V.V., Karpenko S.V., Tumanov K.A., Kochergina E.V., Zelenskaya N.S., Lashkova O.E. Estimating of radiation risks of non-cancer diseases among Russian Cher-nobyl cleanup workers. Radiatsiya i risk – Radiation and Risk, 2021, vol. 30, no. 1, pp. 78-93. (In Russian).
7. Resolution of the Government of the Russian Federation No 592 of 4 November 2004 "On approval of the list of diseases, the occurrence or aggravation of which is caused by radiation exposure as a result of the Cher-nobyl NPP catastrophe, the 1957 accident at the Mayak PA and the discharge of radioactive waste into the Techa River". Available at: https://base.garant.ru/12137458/#block_1000 (Accessed 10.02.2024). (In Russian).
8. ICRP Report on tissue reactions, early and remote effects in normal tissues and organs – threshold doses for tissue reactions in the context of radiation Protection. ICRP Proceedings (Publication 118). Eds.: A.B. Akleev, M.F. Kiselev. Chelyabinsk, Kniga Publ., 2012. 384 p. (In Russian).
9. Skou S.T., Mair F.S., Fortin M., Guthrie B., Nunes B.P., Miranda J.J., Boyd C.M., Pati S., Mtenga S., Smith S.M. Multimorbidity. Nat. Rev. Dis. Primers, 2022, vol. 8, no. 1, pp. 48. DOI: 10.1038/s41572-022-00376-4.
10. Radiation epidemiology of human circulatory system diseases after radiation accidents. Ed.: Corr. Member of RAS V.K. Ivanov. Obninsk, A. Tsyb MRRC, 2016. 168 p. (In Russian).
11. Chekin S.Yu., Gorski A.I., Maksioutov M.A., Karpenko S.V., Shchukina N.V., Kochergina E.V., Lashkova O.E., Zelenskaya N.S. Assessment of radiation risks of cataract morbidity among liquidators of the conse-quences of the accident at the Chernobyl nuclear power plant, allowing for impact of concomitant diseases. Meditsinskaya radiologiya i radiatsionnaya bezopasnost – Medical Radiology and Radiation Safety, 2023, vol. 68, no. 4, pp. 58–68. (In Russian).
12. National Radiation Epidemiological Register. Available at: http://www.nrer.ru/main.html (Accessed 10.02.2024). (In Russian).
13. Knight K., Wade S., Balducci L. Prevalence and outcomes of anemia in cancer: a systematic review of the literature. Am. J. Med., 2004, vol. 116, no. 7A (Suppl.), pp. 11-26.
14. Software “Statistics”. Available at: http://www.statsoft.ru (Accessed 10.02.2024). (In Russian).
15. Agrawal R., Imieliński T., Swami A. Mining association rules between sets of items in large databases. Proceedings of the 1993 ACM SIGMOD International conference on Management of data (SIGMOD'93). New York, 1993, pp. 207-216.
16. Gorski A.I., Maksioutov M.A., Tumanov K.A., Vlasov O.K., Kochergina E.V., Zelenskaya N.S., Chekin S.Yu., Ivanov S.A., Kaprin A.D., Ivanov V.K. Analysis of statistical correlation between radiation dose and cancer mortality among the population residing in areas contaminated with radionuclides after the Chernobyl nuclear power station. Meditsinskaya radiologiya i radiatsionnaya bezopasnost – Medical Radiology and Radiation Safety, 2019, vol. 64, no. 6, pp. 5-11. (In Russian).
17. Breslow N., Day N. Statistical methods in cancer research. Volume II. The design and analysis of cohort studies. IARC Scientific Publication No. 82. Lyon, IARC, 1987. 406 p.
18. Kashcheev V.V., Chekin S.Yu., Karpenko S.V., Maksioutov M.A., Tumanov K.A., Kochergina E.V., Glebova S.E., Ivanov S.A., Kaprin A.D. Estimating of radiation risks of malignant neoplasms among Russian Chernobyl cleanup workers. Radiatsiya i risk – Radiation and Risk, 2021, vol. 30, no. 1, pp. 58-77. (In Russian).
19. Gorski A.I., Chekin S.Yu., Maksioutov M.A., Karpenko S.V., Tumanov K.A., Zelenskaya N.S., Lashkova O.E. Statistical relationship between radiation dose and radiation risks estimates for non-cancer endocrine diseases in liquidators of the Chernobyl accident with account of possible wrong diagnoses established and registered. Radiatsiya i risk – Radiation and Risk, 2023, vol. 32, no. 1, pp. 21-35. (In Russian).
20. Montané E., Ibanez L., Vidal X., Ballarin E., Puig R., Garcia N., Laporte J.R., Catalan Group for Study of Agranulocytosis and Aplastic Anemia. Epidemiology of aplastic anaemia: a prospective multicenter study. Haematologica, 2008, vol. 93, no. 4, pp. 518-523.
21. Issaragrisil S., Leaverton P.E., Chansung K., Thamprasit T., Porapakham Y., Vannasaeng S., Pianki-jagum A., Kaufman D.W., Anderson T.E., Shapiro S., Young N.S. Regional patterns in the incidence of aplastic anemia in Thailand. The Aplastic Anemia Study Group. Am. J. Hematol., 1999, vol. 61, no. 3, pp. 164-168.
22. Chekin S.Yu., Kashcheev V.V., Maksioutov M.A., Menyajlo A.N., Korelo A.M., Lovachev S.S., Kashcheeva P.V. Determination of increased radiation risk group among Russian Chernobyl cleanup workers. Radiatsiya i risk – Radiation and Risk, 2021, vol. 30, no. 1, pp. 147-156. (In Russian).
Full-text article (in Russian)